Joint (NASDAQ:JYNT – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.01 by ($0.02), MarketWatch Earnings reports. Joint had a net margin of 2.81% and a return on equity of 9.54%. The firm had revenue of $29.31 million during the quarter, compared to the consensus estimate of $29.85 million. Joint updated its FY 2023 guidance to EPS.
Joint Trading Up 3.6 %
NASDAQ:JYNT opened at $9.69 on Friday. The stock has a market capitalization of $142.25 million, a price-to-earnings ratio of 46.14 and a beta of 1.44. Joint has a 52 week low of $8.76 and a 52 week high of $20.00. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average of $11.56 and a 200 day moving average of $13.82.
Insiders Place Their Bets
In other Joint news, major shareholder Bandera Partners Llc acquired 25,867 shares of the firm’s stock in a transaction dated Wednesday, September 13th. The stock was purchased at an average price of $9.28 per share, for a total transaction of $240,045.76. Following the acquisition, the insider now owns 3,618,998 shares in the company, valued at approximately $33,584,301.44. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders have bought 846,952 shares of company stock valued at $8,682,663. 4.00% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Joint
Analyst Upgrades and Downgrades
Several research firms have recently commented on JYNT. Roth Mkm reduced their price target on shares of Joint from $16.00 to $13.00 and set a “buy” rating for the company in a report on Thursday. StockNews.com began coverage on shares of Joint in a research note on Thursday, August 17th. They issued a “hold” rating for the company. Finally, Maxim Group lowered Joint from a “buy” rating to a “hold” rating in a research report on Friday, August 11th.
Get Our Latest Analysis on JYNT
About Joint
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.
Read More
- Five stocks we like better than Joint
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 Wrecked Stocks Keeping Cars on the Road Ready for Repair
- What Are Meme Stocks and Are They Viable Investments?
- WeWork Stock Soars: Meme Stock Madness or Mirage?
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Low-Cost ETFs That Are Crushing SPY
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.